Safety of an Intravenous Formulation of Lamotrigine

摘要

ObjectiveIntravenous (IV) formulations are useful when treating patients when oral administration is not possible and to study certain pharmacokinetic parameters such as bioavailability. We developed a stable-labeled IV formulation of lamotrigine (LTG) for studying pharmacokinetics in epilepsy patients.